- Home
- INBK vs NVCT Comparison
INBK vs NVCT Comparison
Compare INBK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- NVCT
- Stock Information
- Founded
- INBK 1999
- NVCT 2020
- Country
- INBK United States
- NVCT United States
- Employees
- INBK N/A
- NVCT N/A
- Industry
- INBK Major Banks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- INBK Finance
- NVCT Health Care
- Exchange
- INBK Nasdaq
- NVCT Nasdaq
- Market Cap
- INBK 196.2M
- NVCT 184.9M
- IPO Year
- INBK N/A
- NVCT 2022
- Fundamental
- Price
- INBK $27.50
- NVCT $7.99
- Analyst Decision
- INBK Buy
- NVCT Strong Buy
- Analyst Count
- INBK 4
- NVCT 3
- Target Price
- INBK $34.50
- NVCT $17.00
- AVG Volume (30 Days)
- INBK 61.2K
- NVCT 181.5K
- Earning Date
- INBK 07-23-2025
- NVCT 08-05-2025
- Dividend Yield
- INBK 0.87%
- NVCT N/A
- EPS Growth
- INBK 27.37
- NVCT N/A
- EPS
- INBK 2.40
- NVCT N/A
- Revenue
- INBK $114,609,000.00
- NVCT N/A
- Revenue This Year
- INBK $6.41
- NVCT N/A
- Revenue Next Year
- INBK $17.52
- NVCT N/A
- P/E Ratio
- INBK $11.55
- NVCT N/A
- Revenue Growth
- INBK 20.13
- NVCT N/A
- 52 Week Low
- INBK $19.54
- NVCT $4.44
- 52 Week High
- INBK $43.27
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- INBK 59.23
- NVCT 48.13
- Support Level
- INBK $26.82
- NVCT $7.91
- Resistance Level
- INBK $28.15
- NVCT $8.39
- Average True Range (ATR)
- INBK 0.76
- NVCT 0.41
- MACD
- INBK -0.08
- NVCT 0.09
- Stochastic Oscillator
- INBK 46.28
- NVCT 61.36
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.